Happy hump day, readers.
It’s a busy week, but I wanted to highlight a piece from my colleague Erin Corbett on the latest, disconcerting data regarding the opioid addiction epidemic.
“According to the [Centers for Disease Control’s] National Center for Health Statistics, drug overdoses involving fentanyl increased by 113% each year between 2013 and 2016. The drug was involved in nearly 29% of all reported overdose deaths in 2016, a huge jump from just 4% five years earlier. At that point, oxycodone was the most common drug in overdoses, at 13%,” Erin writes.
Read on for the day’s news.
J&J claims a head-to-head win in a lucrative space. Johnson & Johnson is ramping up its rivalry with Novartis in one of the most lucrative spaces in pharmaceuticals: dermatology and immunology. The firm is touting its psoriasis treatment Tremfya’s efficacy against Novartis’ rival Cosentyx. The stakes are high: This is a more than $20 billion market. (Reuters)
THE BIG PICTURE
Kaiser mental health strike leads to repercussions. A dispute between mental health workers and Kaiser management has led to the cancellation of certain non-urgent surgeries, according to CBS. Nearly 4,000 workers represented by the National Union of Healthcare Workers will reportedly strike through Friday in a dispute over staffing levels and pay. (CBS News)
More Than 60% of Americans Didn’t Get a Pay Raise Last Year, by Don Reisinger
Commentary: Twitter Has Become the Modern Day Colosseum, by Michael Fontaine
Sesame Street Is Introducing Its First Homeless Puppet, by Emily Price
|Produced by Sy Mukherjee|
Find past coverage. Sign up for other Fortune newsletters.